Аннотация:
Hypertension is one of the main modifiable risk factors for cognitive impairment (CI) and dementia in middle-aged and elderly patients. CI occurs in patients with hypertension even with its short duration and is manifested by controlling dysfunctiona and cognitive speed decline. The paper presents the results of a neuropsychological examination in 50 patients of middle age (47.545.2 years) with short-term (2.65.5 years) and uncomplicated hypertension. Stable blood pressure normalization during antihypertensive therapy improves cognitive function and prevents the progression of CI and the development of dementia. The use of nicergoline in patients with hypertension and CI is discussed.
Остроумова Т. М. Татьяна Максимовна 1991-
Парфенов В. А. Владимир Анатольевич 1957-
Остроумова О. Д. Ольга Дмитриевна 1968-
Ostroumova T. M. Tat`yana Maksimovna 1991-
Parfenov V. A. Vladimir Anatolyevich 1957-
Ostroumova O. D. Ol`ga Dmitrievna 1968-
Hypertension and cognitive impairment: The standpoint of evidence-based medicine
Текст визуальный непосредственный
Неврология, нейропсихиатрия, психосоматика
ИМА-Пресс
Т. 9, Вып. 4 С. 70-76
2017
Статья
Clinical manifestations Cognitive impairment Diagnosis Hypertension Treatment.
Hypertension is one of the main modifiable risk factors for cognitive impairment (CI) and dementia in middle-aged and elderly patients. CI occurs in patients with hypertension even with its short duration and is manifested by controlling dysfunctiona and cognitive speed decline. The paper presents the results of a neuropsychological examination in 50 patients of middle age (47.545.2 years) with short-term (2.65.5 years) and uncomplicated hypertension. Stable blood pressure normalization during antihypertensive therapy improves cognitive function and prevents the progression of CI and the development of dementia. The use of nicergoline in patients with hypertension and CI is discussed.